American Gene Technologies (AGT) is a gene and cell therapeutics company with a proprietary lentiviral platform capable of a variety of applications including large and orphan indications, infectious disease, immune-oncology, and monogenic disorders. It develops an immuno-oncology approach of stimulating gamma-delta (γδ) T cells to attack multiple cancers.